Implant Sciences to provide QS-B220 ETD systems for a French airport

US-based Implant Sciences (IMSC) has secured an order to supply 25 QS-B220 explosives trace detection (ETD) systems for a major airport in France.

The systems will be deployed to screen passengers and check bags, which is the recent European security regulations requirement.

Implant Sciences global sales and marketing vice-president Dr Darryl Jones said: "Our QS-B220 was selected for its superior performance in the airport operating environment. After conducting a long operational performance evaluation at the airport, the QS-B220’s performance was demonstrated to be far superior to the competition.

"This, along with the fact that the QS-B220 is the only non-rad ETD to have both the original STAC (France’s ETD approval) as well as the European Civil Aviation Conference (ECAC) qualification, drove the purchasing decision."

The QS-B220 desktop explosives trace detector is said to use ion mobility spectrometry (IMS) to detect and identify trace amounts of different military, commercial and homemade explosives, as well as illicit drugs.

The trace detection systems feature a radioactive material-free design, push-button maintenance and diagnostics and a patented inCal internal automatic calibration system.

IMSC plans to deliver the systems by the end of its fourth fiscal quarter, which will close on 30 June.

The company produces explosives trace detection and drugs trace detection solutions for homeland security applications.